Research and Developments

Page 13 of 20« First...1112131415...20...Last »

March 8, 2013

Stem Cell Procedures Promising

Posted in: Latest News, Research and Developments

by Dan Roberts (Updated February 20, 2015) Several studies are showing success at using stem cell transplantation to treat retinal degeneration. This article describes the progress of the research. University of Washington In 2006, a team from the University of Washington used a mix of “growth factors”, natural proteins that encourage cell growth, to coax
read more »

December 19, 2012

Aspirin and AMD

Posted in: Research and Developments

by Dan Roberts Updated 12/19/12 This is an attempt to shed some light on the issue of aspirin and macular degeneration. In the spring of 2005, a large study introduced some interesting new information about aspirin. The study was done using 39,876 women over a 10-year period in order to clarify the suspected differences between
read more »

September 27, 2012

Antiangiogenic Drugs Are Stopping Neovascularization in Wet Macular Degeneration

Posted in: Research and Developments

by Dan Roberts A substance in the body called Vascular Endothelial Growth Factor (VEGF) is responsible for the growth of new blood vessels. It promotes this growth by stimulating the endothelial cells, which form the walls of the vessels and transport nutrients and oxygen to the tissues. Evidence shows that when the retinal pigment epithelial
read more »

June 5, 2012

Implantable Miniature Telescope (IMT) For AMD and Stargardt’s Disease

Posted in: Latest News, Research and Developments

by Dan Roberts (Updated: June 5, 2012) The IMT is a micro-sized precision telescope, about the size of a pea, that is implanted in one eye in an outpatient surgical procedure conducted under local anesthesia. The IMT provides magnification of 3.0X or 2.2X, depending on the IMT model used. A magnified image is projected over
read more »

June 1, 2012

Summary of Research and Developments in Macular Degeneration, 2011-2012

Posted in: Research and Developments

by Dan Roberts June 2012 Introduction Here is MD Support’s summary of the the past twelve months of significant research and development in the field of macular degeneration. We begin with the field that has been making the most news: pharmacology. _______________________________ PHARMACOLOGY SEP: Infection Risk From Repackaged Avastin The big pharmaceutical news of the
read more »

April 22, 2012

IL-18 Can Prevent Inflammation in the Retina

Posted in: Research and Developments

by Dan Roberts Updated April 2014 A new finding by researchers at Trinity College Dublin may lead to another treatment for wet AMD. Inflammation in the retina results from blood vessel development, and the natural component named IL-18 has been found to keep the process under control. By injecting the chemical into the eye, or
read more »

March 11, 2012

What Is Macular Degeneration?

Posted in: Daily Living, Eye Conditions, Health and Nutrition, Low Vision Rehabilitation, Research and Developments, Therapies, Treatments, and Procedures

by Dan Roberts (Updated April 29, 2015) (Reviewed by Martin A. Mainster, Ph.D., M.D., FRCOphth) Audio/visual presentations on all related subjects Recommended books: The First Year: Age-Related Macular Degeneration: An Essential Guide for the Newly Diagnosed by Daniel L. Roberts Macular Degeneration: The Complete Guide to Saving and Maximizing Your Sight by Lylas Mogk, M.D.
read more »

February 28, 2012

Fenretinide For Treatment of Dry MD and Stargardt’s Disease

Posted in: Research and Developments

by Dan Roberts (Updated February 28, 2012) Fenretinide (RT-101), a drug that has been used to treat certain cancers, rheumatoid arthritis, acne, and psoriasis, has been found to also slow the production and accumulation of a toxin that leads to vision loss in Stargardt’s patients. The toxin, called A2E, is a byproduct of vitamin A,
read more »

February 9, 2012

New Radiation Treatment for Wet AMD

Posted in: Research and Developments

by Dan Roberts [It was reported on 2/9/12 that Phase III of this study did not meet it’s primary endpoint at 2 years. The information in this article describes the progress up to that point.] NeoVista, Inc. announced on June 17, 2007 the official commencement of the CABERNET (Cnv secondary to Amd treated with BEta
read more »

February 2, 2012

New Treatment for Dry AMD Using HuCNS Stem Cells

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

by Dan Roberts February 2, 2012 StemCells, Inc. announced on February 2, 2012 that the FDA has authorized a Phase I/II clinical trial of a new method using stem cells from the brain to prevent degeneration of the macula in dry AMD patients. Purified human neural stem cells (HuCNS-SC) will be administered by a single
read more »

Page 13 of 20« First...1112131415...20...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann